Cutting sugar
Also called: sugar starvation, no-sugar diet.
Chapter 6 of The Cancer Evidence Handbook, Part Two. Last reviewed 2026-09-16. How this works.
Starving an existing tumour Grade D
No human evidence of benefit, or none that survived testing.
You cannot starve a tumour by avoiding sugar, because the body makes its own and keeps the level steady.
Blood sugar is held steady by the liver whatever you eat.
How this grade was reached
The claim
The claim is that a tumour runs on sugar, so removing sugar from the diet will starve it. It is one of the most common things a person is told after a diagnosis.
What it does
This is where the argument breaks. Blood glucose is not set by the last meal; it is defended by the liver, which makes glucose from other sources whenever intake falls. A person who eats no sugar at all still has glucose in their blood, because the body will not let it drop. There is no dietary route to starving a tumour of it.
The evidence
The laboratory work most often quoted here fed high-fructose corn syrup to mice bred to develop bowel tumours, and reported larger and higher-grade tumours, without the mice becoming obese. Inside the tumours, fructose was converted and fed into the pathways that build fatty acids.1
That is a finding about fructose in a mouse, and the journal that published it said in its own summary that whether the same happens in a person remains to be seen. No human study has tested whether cutting sugar changes the course of a cancer.1
The harm
What has not been looked at
No study has examined what restricting sugar does to a person undergoing cancer treatment. Nobody has shown a benefit, and nobody has measured the cost of the restriction either.
This applies to: restricting sugar during cancer treatment.
Nobody has run a search to establish this, so it is the register’s reading of what exists rather than a gap somebody has looked for and confirmed.
What has not been shown
No trial in people has tested whether cutting sugar changes what a cancer does. The evidence here is a mouse study about fructose.
This applies to: any tumour type, any endpoint.
Established by trial scope, checked 2026-09-16. Result: the only source in this record is a mouse experiment.1
What to ask
Is there anything about my diet that would actually change how my treatment works?
When to call your team, and what to tell them
If you have changed how you eat because of something you have read, or are thinking about it, the people treating you can only weigh that if they know about it. That is true when nothing has been written down here, and it is most true then.
The register records no warning signs for this entry. Anyone losing weight during treatment should tell their team, whatever the reason.
Also recorded for this entry
Does it reach the body?
This is a way of eating rather than a compound that reaches a concentration in the blood, so the dish-to-person comparison does not apply to it. What that question means, for every compound here.
Does it clash with a cancer treatment?
A change in what someone eats is not checked against treatment classes in this register.
Every recorded interaction, and how to turn it into a request for your pharmacist.
Trials
This is a general dietary change rather than an intervention with recruiting trials attached.
References
Goncalves MD, Lu C, Tutnauer J, et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Science 2019;363(6433):1345-1349.
How this was reached: taken from the book's notes, chapter 6, note 2. The author names are abbreviated in the source that was read, and have not been filled in here.